NCT04260425

Brief Summary

The trial will use a two period acute double-blind cross-over design to compare the effects of a serving of oatmeal containing high or low amounts of avenanthramides (AV) on post-prandial blood glucose response in healthy adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 5, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 7, 2020

Completed
1.8 years until next milestone

Study Start

First participant enrolled

November 28, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 28, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 28, 2022

Completed
Last Updated

September 13, 2022

Status Verified

September 1, 2022

Enrollment Period

4 months

First QC Date

February 5, 2020

Last Update Submit

September 12, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • post-prandial glucose response

    2 hour area under the curve of post-prandial glucose response to the interventions in mmol/L\*min\^2

    Area under the curve from 0,15, 30, 45, 60, 90 and 120 minutes

Study Arms (2)

High then low avenanthramides content oats

EXPERIMENTAL

This arm will receive the high avenanthramides content oatmeal at the first session and the low avenanthramides content oatmeal at the second session. Sessions will be at least 5 days apart.

Other: Serving of oatmeal made from low avenanthramides oats and waterOther: Serving of oatmeal made from high avenanthramides oats and water

Low then high avenanthramides content oats

EXPERIMENTAL

This arm will receive the low avenanthramides content oatmeal at the first session and the high avenanthramides content oatmeal at the second session. Sessions will be at least 5 days apart.

Other: Serving of oatmeal made from low avenanthramides oats and waterOther: Serving of oatmeal made from high avenanthramides oats and water

Interventions

One serving size (40 grams dry weight) of low avenanthramides oats flakes will be used to make oatmeal. One cup of water and a dash of salt (0.72 g) will be added into the treatment and microwaved on high for 3 minutes. It will be stirred before serving. Ingredients and cooking time will be consistently maintained throughout.

High then low avenanthramides content oatsLow then high avenanthramides content oats

One serving size (40 grams dry weight) of high avenanthramides oats flakes will be used to make oatmeal. One cup of water and a dash of salt (0.72 g) will be added into the treatment and microwaved on high for 3 minutes. It will be stirred before serving. Ingredients and cooking time will be consistently maintained throughout.

High then low avenanthramides content oatsLow then high avenanthramides content oats

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Participant is willing and able to give informed consent for participation in the trial
  • Male or female between 18-50 years old
  • BMI range in between 18.9-29.9 kg/m\^2
  • Fasting glucose \<5.6 mmol/L
  • Usually eat breakfast
  • In the Investigator's opinion is able and willing to comply with all trial requirements

You may not qualify if:

  • Fasting glucose ≥ 5.6 mmol/L or \<3.5 mmol/L
  • Female participant who is pregnant, lactating or planning pregnancy during the course of the trial
  • Participants who indicate that they could not finish consuming the study treatments within 10 minutes
  • Use of medication or supplements that may influence carbohydrate metabolism, including, but not limited to adrenergic blockers, diuretics, thiazolidinediones, metformin and systemic corticosteroids within 4 weeks of screening visit
  • History of disordered eating, AIDS, hepatitis, a history of clinically important endocrine (including Type I and Type II diabetes mellitus), cardiovascular (including but not limit to atherosclerotic disease, history of myocardial infarction, peripheral arterial disease, stroke), pulmonary, biliary or GI disorders
  • Intolerance or allergic reaction to oats
  • Existing restrictive dietary habits (such a vegan, low carbohydrate or keto)
  • Uncontrolled hypertension
  • History of cancer within the last two years (except for non-melanoma skin cancer)
  • Recent history of (within 12 month of screening) or current strong potential for alcohol or substance abuse. Alcohol abuse is defined as \>14 drinks per week, (1 drink = 12oz of beer, 5oz of wine or 1.5oz distilled spirits)
  • Body weight change over 3.5kg within the past 3 months
  • Participants who have participated in another research trial involving an investigational product in the past 12 weeks
  • Had significant physical trauma or major surgery in the past 3 month or had trauma or major surgery in the past 3 month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Richardson Center for Food Technology and Research

Winnipeg, Manitoba, R3T 2E1, Canada

Location

MeSH Terms

Interventions

Water

Intervention Hierarchy (Ancestors)

HydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen Compounds

Study Officials

  • Dylan Mackay, PhD

    University of Manitoba

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 5, 2020

First Posted

February 7, 2020

Study Start

November 28, 2021

Primary Completion

March 28, 2022

Study Completion

March 28, 2022

Last Updated

September 13, 2022

Record last verified: 2022-09

Locations